Patrick Smith is the leader of Gowling WLG’s Calgary office’s IP Practice Group and is a member of the firm’s Patents and Life Sciences Groups. He is also a registered patent agent. Patrick provides strategic patent, trademark, regulatory, and life-cycle advice to clients in the oil and gas, pharmaceutical, agriculture, biotech, and chemical industries. He has appeared as counsel in more than 100 reported decisions relating to patents, trademarks, and copyright in the Ontario Court, Federal Court, and Supreme Court of Canada, including the precedent-setting case Teva v. Pfizer. He has successfully represented clients such as AstraZeneca, Baker Petrolite, Eli Lilly, Pfizer, Merck, Janssen, Schering-Plough, Bristol-Myers Squibb, Dow AgroSciences, Allergan, Bayer, Purdue pharmaceuticals, and Amgen on litigation matters. Patrick was president of the Intellectual Property Intellectual Institute of Canada (IPIC) 2018–2019. Patrick is a regular writer and speaker on key IP issues impacting companies operating in Canada and a former Adjunct Professor of law at the University of Ottawa. He has been recognized in Chambers Canada, IAM Patent 1000, Managing IP’s IP Patent Stars, The CanadianLegal Lexpert® Directory, and The Best Lawyers in Canada.